Advertisement
Advertisement

ATOS

ATOS logo

Atossa Therapeutics, Inc. Common Stock

4.52
USD
Sponsored
-0.03
-0.66%
Jun 09, 15:44 UTC -4
Open

ATOS Earnings Reports

Positive Surprise Ratio

ATOS beat 21 of 33 last estimates.

64%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$1.09
Implied change from Q1 26 (Revenue/ EPS)
--
/
-1.80%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+3.81%

Atossa Therapeutics, Inc. Common Stock earnings per share and revenue

On May 08, 2026, ATOS reported earnings of -1.11 USD per share (EPS) for Q1 26, beating the estimate of -6.24 USD, resulting in a 82.23% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.23% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -1.09 USD, with revenue projected to reach -- USD, implying an decrease of -1.80% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Autonomix Medical, Inc. Common Stock
Report Date
May 27, 2026 For Q4 26
Estimate
-$0.26
Actual
-$0.23
Surprise
+13.27%
logo
Mesa Laboratories Inc
Report Date
May 27, 2026 For Q4 26
Estimate
$0.34
Actual
-$0.75
Surprise
-316.26%
FAQ
For Q1 2026, Atossa Therapeutics, Inc. Common Stock reported EPS of -$1.11, beating estimates by 82.23%, and revenue of $0.00, 0% as expectations.
The stock price moved down -1.23%, changed from $5.67 before the earnings release to $5.60 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 5 analysts, Atossa Therapeutics, Inc. Common Stock is expected to report EPS of -$1.09 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement